| Code | 3799A | ||||||||||
| MA number | 10/0015/13-S | ||||||||||
| Product Form: | tbl 50x400 mg (tuba PP/PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
| Therapeutic Class: | 10 - ANTHELMINTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 23.01.2013 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Zentel 400mg tbl_marec2021.pdf
|
| SPC: |
SPC_Zentel 400mg tbl_marec2021.pdf
|
| Safety feature | Yes |
| Data update: | 15.05.2018 |
